UB Paderborn / Katalog / Suche / in CDI

Agonist anti-GITR monoclonal antibody induces melanoma tumor immunity in mice by altering regulatory T cell stability and intra-tumor accumulation

PloS one, 2010-05, Vol.5 (5), p.e10436-e10436

2010

Volltextzugriff (PDF)

Alphavirus replicon particles expressing TRP-2 provide potent therapeutic effect on melanoma through activation of humoral and cellular immunity

PloS one, 2010-09, Vol.5 (9), p.e12670

2010

Volltextzugriff (PDF)

Cyclophosphamide enhances immunity by modulating the balance of dendritic cell subsets in lymphoid organs

Blood, 2010-06, Vol.115 (22), p.4384-4392

2010

Volltextzugriff (PDF)

Two Distinct Categories of Focal Deletions in Cancer Genomes

PloS one, 2013-06, Vol.8 (6), p.e66264

2013

Volltextzugriff (PDF)

Glucocorticoid-Induced TNF Receptor Family Related Gene Activation Overcomes Tolerance/Ignorance to Melanoma Differentiation Antigens and Enhances Antitumor Immunity

Journal of Immunology, 2006-06, Vol.176 (11), p.6434-6442

2006

Volltextzugriff (PDF)

Role for dipeptidyl peptidase IV in tumor suppression of human non small cell lung carcinoma cells

International journal of cancer, 2004-05, Vol.109 (6), p.855-866

2004

Volltextzugriff (PDF)

Innate immune response of human plasmacytoid dendritic cells to poxvirus infection is subverted by vaccinia E3 via its Z-DNA/RNA binding domain

PloS one, 2012-05, Vol.7 (5), p.e36823-e36823

2012

Volltextzugriff (PDF)

Classification and Subtype Prediction of Adult Soft Tissue Sarcoma by Functional Genomics

The American journal of pathology, 2003-08, Vol.163 (2), p.691-700

2003

Volltextzugriff (PDF)

Immunization of High-Risk Breast Cancer Patients with Clustered sTn-KLH Conjugate plus the Immunologic Adjuvant QS-21

Clinical cancer research, 2007-05, Vol.13 (10), p.2977-2985

2007

Volltextzugriff (PDF)

Myxoma Virus Induces Type I Interferon Production in Murine Plasmacytoid Dendritic Cells via a TLR9/MyD88-, IRF5/IRF7-, and IFNAR-Dependent Pathway

Journal of Virology, 2011-10, Vol.85 (20), p.10814-10825

2011

Volltextzugriff (PDF)

Cyclophosphamide enhances the antitumor potency of GITR engagement by increasing oligoclonal cytotoxic T cell fitness

JCI insight, 2021-10, Vol.6 (20)

2021

Volltextzugriff (PDF)

Classification of Clear-Cell Sarcoma as a Subtype of Melanoma by Genomic Profiling

Journal of clinical oncology, 2003-05, Vol.21 (9), p.1775-1781

2003

Volltextzugriff (PDF)

Monocytic CCR2+ Myeloid-Derived Suppressor Cells Promote Immune Escape by Limiting Activated CD8 T-cell Infiltration into the Tumor Microenvironment

Cancer research (Chicago, Ill.), 2012-02, Vol.72 (4), p.876-886

2012

Volltextzugriff (PDF)

Blockade of surface-bound TGF-β on regulatory T cells abrogates suppression of effector T cell function in the tumor microenvironment

Science signaling, 2017-08, Vol.10 (494)

2017

Volltextzugriff (PDF)

Enhanced responses to tumor immunization following total body irradiation are time-dependent

PloS one, 2013-12, Vol.8 (12), p.e82496-e82496

2013

Volltextzugriff (PDF)

Induction of tumoricidal function in CD4+ T cells is associated with concomitant memory and terminally differentiated phenotype

The Journal of experimental medicine, 2012-10, Vol.209 (11), p.2113-2126

2012

Volltextzugriff (PDF)

Phase II Study of Temozolomide Plus Thalidomide for the Treatment of Metastatic Melanoma

Journal of clinical oncology, 2003-09, Vol.21 (17), p.3351-3356

2003

Volltextzugriff (PDF)

Detection of intra-tumor self antigen recognition during melanoma tumor progression in mice using advanced multimode confocal/two photon microscope

PloS one, 2011-06, Vol.6 (6), p.e21214-e21214

2011

Volltextzugriff (PDF)

Focus on melanoma

Cancer cell, 2002-10, Vol.2 (4), p.275-278

2002

Volltextzugriff (PDF)

Cutting Edge: OX40 Agonists Can Drive Regulatory T Cell Expansion if the Cytokine Milieu Is Right

The Journal of immunology (1950), 2009-10, Vol.183 (8), p.4853-4857

2009

Volltextzugriff (PDF)

GITR pathway activation abrogates tumor immune suppression through loss of regulatory T cell lineage stability

Cancer immunology research, 2013-11, Vol.1 (5), p.320-331

2013

Volltextzugriff (PDF)

Concomitant tumor immunity to a poorly immunogenic melanoma is prevented by regulatory T cells

The Journal of experimental medicine, 2004-09, Vol.200 (6), p.771-782

2004

Volltextzugriff (PDF)

Immunity to melanoma: unraveling the relation of tumor immunity and autoimmunity

Oncogene, 2003-05, Vol.22 (20), p.3180-3187

2003

Volltextzugriff (PDF)

T cell receptor associated with naturally occurring human tumor immunity

Proceedings of the National Academy of Sciences - PNAS, 2007-11, Vol.104 (48), p.19073-19078

2007

Volltextzugriff (PDF)

OX40 engagement and chemotherapy combination provides potent antitumor immunity with concomitant regulatory T cell apoptosis

The Journal of experimental medicine, 2009-05, Vol.206 (5), p.1103-1116

2009

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Agonist anti-GITR monoclonal antibody induces melanoma tumor immunity in mice by altering regulatory T cell stability and intra-tumor accumulation

Alphavirus replicon particles expressing TRP-2 provide potent therapeutic effect on melanoma through activation of humoral and cellular immunity

Cyclophosphamide enhances immunity by modulating the balance of dendritic cell subsets in lymphoid organs

Two Distinct Categories of Focal Deletions in Cancer Genomes

Glucocorticoid-Induced TNF Receptor Family Related Gene Activation Overcomes Tolerance/Ignorance to Melanoma Differentiation Antigens and Enhances Antitumor Immunity

Role for dipeptidyl peptidase IV in tumor suppression of human non small cell lung carcinoma cells

Innate immune response of human plasmacytoid dendritic cells to poxvirus infection is subverted by vaccinia E3 via its Z-DNA/RNA binding domain

Classification and Subtype Prediction of Adult Soft Tissue Sarcoma by Functional Genomics

Immunization of High-Risk Breast Cancer Patients with Clustered sTn-KLH Conjugate plus the Immunologic Adjuvant QS-21

Myxoma Virus Induces Type I Interferon Production in Murine Plasmacytoid Dendritic Cells via a TLR9/MyD88-, IRF5/IRF7-, and IFNAR-Dependent Pathway

Cyclophosphamide enhances the antitumor potency of GITR engagement by increasing oligoclonal cytotoxic T cell fitness

Classification of Clear-Cell Sarcoma as a Subtype of Melanoma by Genomic Profiling

Monocytic CCR2+ Myeloid-Derived Suppressor Cells Promote Immune Escape by Limiting Activated CD8 T-cell Infiltration into the Tumor Microenvironment

Blockade of surface-bound TGF-β on regulatory T cells abrogates suppression of effector T cell function in the tumor microenvironment

Enhanced responses to tumor immunization following total body irradiation are time-dependent

Induction of tumoricidal function in CD4+ T cells is associated with concomitant memory and terminally differentiated phenotype

Phase II Study of Temozolomide Plus Thalidomide for the Treatment of Metastatic Melanoma

Detection of intra-tumor self antigen recognition during melanoma tumor progression in mice using advanced multimode confocal/two photon microscope

Focus on melanoma

Cutting Edge: OX40 Agonists Can Drive Regulatory T Cell Expansion if the Cytokine Milieu Is Right

GITR pathway activation abrogates tumor immune suppression through loss of regulatory T cell lineage stability

Concomitant tumor immunity to a poorly immunogenic melanoma is prevented by regulatory T cells

Immunity to melanoma: unraveling the relation of tumor immunity and autoimmunity

T cell receptor associated with naturally occurring human tumor immunity

OX40 engagement and chemotherapy combination provides potent antitumor immunity with concomitant regulatory T cell apoptosis

Suchergebnisse filtern